- GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas
Toshiaki Haraguchi et al, 2016, PLOS ONE CrossRef - Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
Maria Tsoli et al, 2018, Cancer Biology & Therapy CrossRef - ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
Minsun Jung et al, 2022, Archives of Pathology & Laboratory Medicine CrossRef - CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis
Noriaki Yoshida et al, 2016, The Journal of Pathology CrossRef - Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Anke E. M. van Erp et al, 2017, Targeted Oncology CrossRef - Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis
Chuanxi Zheng et al, 2022, BMC Musculoskeletal Disorders CrossRef - ALKATI interacts with c-Myc and promotes cancer stem cell-like properties in sarcoma
Bu-Shu Xu et al, 2020, Oncogene CrossRef - ALK, NUT, and TRK Do Not Play Relevant Roles in Gastric Cancer—Results of an Immunohistochemical Study in a Large Series
Marie-Isabelle GlĂĽckstein et al, 2022, Diagnostics CrossRef - Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes
Emmy D.G. Fleuren et al, 2017, Cancer Research CrossRef